Abstract
The cardiovascular morbidity and mortality are increased in rheumatoid arthritis and probably equal those of patients with type 2 diabetes mellitus. The European League Against Rheumatism has recently provided evidence-based guidelines for cardiovascular risk management in patients with rheumatoid arthritis and we here briefly summarise these guidelines and other recent data in this area of research.
Bidragets oversatte titel | [Excess mortality from cardiovascular disease in patients with rheumatoid arthritis] |
---|---|
Originalsprog | Dansk |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 173 |
Udgave nummer | 5 |
Sider (fra-til) | 343-6 |
Antal sider | 4 |
Status | Udgivet - 31 jan. 2011 |